Clinical Trial Update: Mitomycin C Therapy for Patients With Primary Sclerosing Cholangitis [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial evaluating Mutamycin (mitomycin C) therapy for patients with Primary Sclerosing Cholangitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• Mutamycin (Mitomycin C)

Snippet

Sponsor: Li, Zhiping, M.D. | Conditions: Primary Sclerosing Cholangitis | Phase 2 | Status: UNKNOWN